Aurora Investment Counsel Boosted Its Patrick Industries (PATK) Position; As Fate Therapeutics (FATE) Shares Rose, Shareholder Wexford Capital LP Has Upped Stake

Aurora Investment Counsel increased its stake in Patrick Industries Inc. (PATK) by 113.77% based on its latest 2018Q4 regulatory filing with the SEC. Aurora Investment Counsel bought 16,794 shares as the company’s stock rose 15.31% with the market. The institutional investor held 31,555 shares of the basic industries company at the end of 2018Q4, valued at $934,000, up from 14,761 at the end of the previous reported quarter. Aurora Investment Counsel who had been investing in Patrick Industries Inc. for a number of months, seems to be bullish on the $1.32B market cap company. The stock increased 2.35% or $1.27 during the last trading session, reaching $55.39. About 167,345 shares traded. Patrick Industries, Inc. (NASDAQ:PATK) has declined 21.76% since April 17, 2018 and is downtrending. It has underperformed by 26.13% the S&P500. Some Historical PATK News: 18/05/2018 – PATRICK INDUSTRIES INC – INCREASED SHARE REPURCHASE AUTHORIZATION INCLUDES AMOUNT REMAINING UNDER PREVIOUS AUTHORIZATION; 21/04/2018 – DJ Patrick Industries Inc, Inst Holders, 1Q 2018 (PATK); 26/04/2018 – Patrick Industries 1Q Net $30.1M; 31/05/2018 – Patrick Industries, Inc. Completes Acquisition Of Dowco, Inc; 18/05/2018 – Patrick Industries Raises Buyback Authorization to $50M Over the Next 24 Mos; 22/03/2018 – Patrick Industries Closes Below 50-Day Average: Technicals; 26/04/2018 – Patrick Industries Closes Above 200-Day Average: Technicals; 19/03/2018 – PATRICK INDUSTRIES BUYS COLLINS & CO. FOR ABOUT $36.5M; 18/05/2018 – Patrick Industries, Inc. Announces Increased Share Repurchase Authorization; 19/03/2018 Patrick Industries, Inc. Completes Acquisition of Collins & Company, Inc

Wexford Capital Lp increased its stake in Fate Therapeutics Inc (FATE) by 248.69% based on its latest 2018Q4 regulatory filing with the SEC. Wexford Capital Lp bought 79,082 shares as the company’s stock rose 17.82% with the market. The hedge fund held 110,882 shares of the health care company at the end of 2018Q4, valued at $1.42 million, up from 31,800 at the end of the previous reported quarter. Wexford Capital Lp who had been investing in Fate Therapeutics Inc for a number of months, seems to be bullish on the $1.01 billion market cap company. The stock decreased 6.24% or $1.03 during the last trading session, reaching $15.47. About 634,660 shares traded. Fate Therapeutics, Inc. (NASDAQ:FATE) has risen 42.48% since April 17, 2018 and is uptrending. It has outperformed by 38.11% the S&P500. Some Historical FATE News: 10/05/2018 – Invus Public Equities Advisors Buys 1.6% of Fate Therapeutics; 10/05/2018 – Fate Therapeutics 1Q Loss/Shr 27c; 10/04/2018 – Fate Therapeutics at Deutsche Bank Health Care Conference May 9; 29/03/2018 – FATE: BOTH DOSES WELL-TOLERATED; 16/05/2018 – FATE GAINS ACCESS TO IP FOR GENE-EDITED T-CELL IMMUNOTHERAPIES; 05/03/2018 – FATE THERAPEUTICS INC QTRLY SHR LOSS $0.29; 10/05/2018 – FATE THERAPEUTICS INC QTRLY SHR LOSS $0.27; 08/05/2018 – Fate Therapeutics at Deutsche Bank Conference Tomorrow; 16/05/2018 – Fate Therapeutics and Memorial Sloan Kettering Cancer Center Expand Scope of License Agreement to include Gene-edited T-cell lmmunotherapies; 03/05/2018 – Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2018 Financial Results

Investors sentiment increased to 1.13 in Q4 2018. Its up 0.17, from 0.96 in 2018Q3. It increased, as 39 investors sold PATK shares while 55 reduced holdings. 39 funds opened positions while 67 raised stakes. 20.91 million shares or 3.04% less from 21.57 million shares in 2018Q3 were reported. 649,858 were accumulated by State Street Corp. Matarin Capital Mngmt Lc has 0% invested in Patrick Industries, Inc. (NASDAQ:PATK). Brant Point Inv has invested 0.03% of its portfolio in Patrick Industries, Inc. (NASDAQ:PATK). Louisiana State Employees Retirement reported 0.01% in Patrick Industries, Inc. (NASDAQ:PATK). State Common Retirement Fund has 49,068 shares. Neuberger Berman Gp Ltd Limited Liability Company invested in 0.03% or 609,319 shares. 185,147 are owned by Nokomis Capital Limited Liability Corporation. Pacific Ridge Prtnrs Ltd Llc, Oregon-based fund reported 18,450 shares. Riverhead Cap Ltd Liability invested in 2,500 shares or 0% of the stock. Moreover, Ima Wealth Inc has 0% invested in Patrick Industries, Inc. (NASDAQ:PATK) for 22 shares. Moreover, Nj State Employees Deferred Compensation Plan has 0.07% invested in Patrick Industries, Inc. (NASDAQ:PATK) for 11,000 shares. D E Shaw And Co holds 0% or 64,051 shares. Moreover, King Luther Cap Management has 0% invested in Patrick Industries, Inc. (NASDAQ:PATK) for 7,585 shares. Citadel Ltd holds 0% of its portfolio in Patrick Industries, Inc. (NASDAQ:PATK) for 137,568 shares. 157,075 are owned by Charles Schwab Mgmt.

Since October 31, 2018, it had 4 insider purchases, and 5 selling transactions for $16.44 million activity. WELCH M SCOTT bought $303,500 worth of Patrick Industries, Inc. (NASDAQ:PATK) on Friday, December 14. Another trade for 30,000 shares valued at $925,615 was bought by Cleveland Todd M. $107,872 worth of stock was sold by Blosser Courtney on Thursday, December 6.

Aurora Investment Counsel, which manages about $238.26 million and $183.72M US Long portfolio, decreased its stake in O’reilly Automotive Inc. (NASDAQ:ORLY) by 1,379 shares to 6,367 shares, valued at $2.19M in 2018Q4, according to the filing. It also reduced its holding in Telus Corporation (NYSE:TU) by 26,350 shares in the quarter, leaving it with 26,713 shares, and cut its stake in Arthur J. Gallagher & Co. (NYSE:AJG).

More notable recent Patrick Industries, Inc. (NASDAQ:PATK) news were published by: Seekingalpha.com which released: “Patrick Industries +8% post Q4 earnings beats – Seeking Alpha” on February 14, 2019, also Nasdaq.com with their article: “PATK vs. IBP: Which Stock Should Value Investors Buy Now? – Nasdaq” published on April 03, 2019, Seekingalpha.com published: “Patrick Industries Inc. Is A Buy – Seeking Alpha” on July 13, 2018. More interesting news about Patrick Industries, Inc. (NASDAQ:PATK) were released by: Seekingalpha.com and their article: “More Bad News Could Sting Patrick Industries – Seeking Alpha” published on December 31, 2018 as well as Nasdaq.com‘s news article titled: “Tuesday 12/18 Insider Buying Report: HDS, PATK – Nasdaq” with publication date: December 18, 2018.

Investors sentiment decreased to 1.6 in Q4 2018. Its down 0.50, from 2.1 in 2018Q3. It dropped, as 15 investors sold FATE shares while 27 reduced holdings. 25 funds opened positions while 42 raised stakes. 53.61 million shares or 5.94% more from 50.60 million shares in 2018Q3 were reported. 10,977 are held by Creative Planning. Grp One Trading LP reported 0% of its portfolio in Fate Therapeutics, Inc. (NASDAQ:FATE). Jpmorgan Chase & owns 459,893 shares. Federated Investors Pa invested 0.01% of its portfolio in Fate Therapeutics, Inc. (NASDAQ:FATE). Tiaa Cref Investment Ltd holds 0% or 100,339 shares in its portfolio. Glenmede Na holds 0% in Fate Therapeutics, Inc. (NASDAQ:FATE) or 1,070 shares. Bancshares Of America De owns 44,925 shares or 0% of their US portfolio. Alps Advsrs holds 0.01% or 149,103 shares in its portfolio. Vanguard Grp Inc reported 2.54M shares. Citigroup holds 0% or 70,941 shares in its portfolio. Raymond James & Assocs reported 27,438 shares or 0% of all its holdings. Alpinvest Partners Bv stated it has 26,925 shares or 0.99% of all its holdings. Zurcher Kantonalbank (Zurich Cantonalbank) stated it has 0% in Fate Therapeutics, Inc. (NASDAQ:FATE). Blume Cap Management has invested 0.01% in Fate Therapeutics, Inc. (NASDAQ:FATE). Aqr Capital Lc reported 0% in Fate Therapeutics, Inc. (NASDAQ:FATE).

Wexford Capital Lp, which manages about $6.34 billion and $1.17B US Long portfolio, decreased its stake in Mosaic Co New (NYSE:MOS) by 45,605 shares to 351,724 shares, valued at $10.27 million in 2018Q4, according to the filing. It also reduced its holding in Viper Energy Partners Lp (NASDAQ:VNOM) by 1.38 million shares in the quarter, leaving it with 35,208 shares, and cut its stake in Inphi Corp (NYSE:IPHI).

Since December 11, 2018, it had 0 insider purchases, and 12 selling transactions for $16.60 million activity. Another trade for 25,000 shares valued at $400,000 was sold by TAHL CINDY.

More notable recent Fate Therapeutics, Inc. (NASDAQ:FATE) news were published by: Streetinsider.com which released: “Fate Therapeutics (FATE) Reports First Patient Treatwed with FT500 Successfully Completes Initial Safety Assessment – StreetInsider.com” on April 02, 2019, also Nasdaq.com with their article: “Battle for last Islamic State enclave edges towards its end – Nasdaq” published on March 20, 2019, Nasdaq.com published: “Owens Corning: What to Do When the Roof Caves In – Nasdaq” on April 15, 2019. More interesting news about Fate Therapeutics, Inc. (NASDAQ:FATE) were released by: Globenewswire.com and their article: “Investor Expectations to Drive Momentum within Fate Therapeutics, Nuance Communications, DHT, Hess Midstream Partners LP, Hamilton Lane, and Mid-America Apartment Communities — Discovering Underlying Factors of Influence – GlobeNewswire” published on April 10, 2019 as well as Nasdaq.com‘s news article titled: “Red Cross seeks news on fate of three staff missing in Syria since 2013 – Nasdaq” with publication date: April 15, 2019.

Fate Therapeutics, Inc. (NASDAQ:FATE) Institutional Positions Chart